2025 Q2 -tulosraportti
214 päivää sitten
‧37 min
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 2 500 | - | - | ||
| 1 000 | - | - | ||
| 4 700 | - | - | ||
| 2 470 | - | - | ||
| 2 500 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2025 Q4 -tulosraportti 15.4. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 | ||
2023 Q3 -tulosraportti 9.11.2023 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·33 min sittenThe big question is: “How long dares Big Pharma to wait” This is, as previously described, a new valuation for Circio, and only the beginning of the many Triggers. What one should keep an eye on is the announcement on April 13th - Here, with all probability, new information will come to the table. At the same time, eyes should not only be directed at collaboration agreements, but agreements with payment involved - The collaboration with united last week was not financed “No sum of money disclosed”. Many also ask “What will it open at tomorrow” and “Is it too late to enter” and let me just make it clear so we avoid all these questions - Do your own research!! If someone knew if it would open at 10, 11 or 12, we would all have booked the next flight to Mars… If one has invested too much and gets a bit nervous with small drops, then I would probably recommend that one either secure profits or take out your total investment, so that one technically sits with the “profit” in Circio - In this case, one would sit “risk-free” This is not a buy/sell recommendation!!!! Wow some weeks🤯🙌
·25 min sittenOne can read news from the Pharma sector on medwatch.no also, much useful info there.
·52 min sittenIt never fails. When one sees a stock rise a lot, some come forward with "pump&dump", "it dips" etc. Of course, the stock has risen a lot lately, but it has also consolidated on the way up. It has also had red days. I have read presentations that have been released. It is quite special that the company is compared to other companies that have been sold for significantly higher sums than mcap today. This in preclinical phase as I have understood it. I also don't believe that those who buy are only shareholders who sit and read on various forums that one must buy. If it were to go to hell....yes, then it goes to hell. No one needs to sit and remind others that it can go to hell. Everyone knows that, but it can also go to heaven and that is probably why we are here.....
·6 min sittenNo stop stop stop, when something forms a blow off top, it will undeniably make a violent correction as well, people said exactly the same about pixelfox, GME, AMC and all other times it has happened, and 10/10 times there is a huge correction when people take profit.
·56 min sittenthis is high risk, high reward. if the company is not acquired by the giants e.g. Pfizer, Roche, Novartis then they can collapse and it is common to see biotech companies collapse when they run out of money·27 min sittenI myself lost some money in BergenBio when it was hyped up to the sky. But I feel much safer here, these two are not comparable. But just a reminder that one must do their own research and not just read in the forums
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q2 -tulosraportti
214 päivää sitten
‧37 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·33 min sittenThe big question is: “How long dares Big Pharma to wait” This is, as previously described, a new valuation for Circio, and only the beginning of the many Triggers. What one should keep an eye on is the announcement on April 13th - Here, with all probability, new information will come to the table. At the same time, eyes should not only be directed at collaboration agreements, but agreements with payment involved - The collaboration with united last week was not financed “No sum of money disclosed”. Many also ask “What will it open at tomorrow” and “Is it too late to enter” and let me just make it clear so we avoid all these questions - Do your own research!! If someone knew if it would open at 10, 11 or 12, we would all have booked the next flight to Mars… If one has invested too much and gets a bit nervous with small drops, then I would probably recommend that one either secure profits or take out your total investment, so that one technically sits with the “profit” in Circio - In this case, one would sit “risk-free” This is not a buy/sell recommendation!!!! Wow some weeks🤯🙌·25 min sittenOne can read news from the Pharma sector on medwatch.no also, much useful info there.
- ·52 min sittenIt never fails. When one sees a stock rise a lot, some come forward with "pump&dump", "it dips" etc. Of course, the stock has risen a lot lately, but it has also consolidated on the way up. It has also had red days. I have read presentations that have been released. It is quite special that the company is compared to other companies that have been sold for significantly higher sums than mcap today. This in preclinical phase as I have understood it. I also don't believe that those who buy are only shareholders who sit and read on various forums that one must buy. If it were to go to hell....yes, then it goes to hell. No one needs to sit and remind others that it can go to hell. Everyone knows that, but it can also go to heaven and that is probably why we are here.....·6 min sittenNo stop stop stop, when something forms a blow off top, it will undeniably make a violent correction as well, people said exactly the same about pixelfox, GME, AMC and all other times it has happened, and 10/10 times there is a huge correction when people take profit.
- ·56 min sittenthis is high risk, high reward. if the company is not acquired by the giants e.g. Pfizer, Roche, Novartis then they can collapse and it is common to see biotech companies collapse when they run out of money·27 min sittenI myself lost some money in BergenBio when it was hyped up to the sky. But I feel much safer here, these two are not comparable. But just a reminder that one must do their own research and not just read in the forums
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 2 500 | - | - | ||
| 1 000 | - | - | ||
| 4 700 | - | - | ||
| 2 470 | - | - | ||
| 2 500 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2025 Q4 -tulosraportti 15.4. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 | ||
2023 Q3 -tulosraportti 9.11.2023 |
2025 Q2 -tulosraportti
214 päivää sitten
‧37 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2025 Q4 -tulosraportti 15.4. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 | ||
2023 Q3 -tulosraportti 9.11.2023 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·33 min sittenThe big question is: “How long dares Big Pharma to wait” This is, as previously described, a new valuation for Circio, and only the beginning of the many Triggers. What one should keep an eye on is the announcement on April 13th - Here, with all probability, new information will come to the table. At the same time, eyes should not only be directed at collaboration agreements, but agreements with payment involved - The collaboration with united last week was not financed “No sum of money disclosed”. Many also ask “What will it open at tomorrow” and “Is it too late to enter” and let me just make it clear so we avoid all these questions - Do your own research!! If someone knew if it would open at 10, 11 or 12, we would all have booked the next flight to Mars… If one has invested too much and gets a bit nervous with small drops, then I would probably recommend that one either secure profits or take out your total investment, so that one technically sits with the “profit” in Circio - In this case, one would sit “risk-free” This is not a buy/sell recommendation!!!! Wow some weeks🤯🙌·25 min sittenOne can read news from the Pharma sector on medwatch.no also, much useful info there.
- ·52 min sittenIt never fails. When one sees a stock rise a lot, some come forward with "pump&dump", "it dips" etc. Of course, the stock has risen a lot lately, but it has also consolidated on the way up. It has also had red days. I have read presentations that have been released. It is quite special that the company is compared to other companies that have been sold for significantly higher sums than mcap today. This in preclinical phase as I have understood it. I also don't believe that those who buy are only shareholders who sit and read on various forums that one must buy. If it were to go to hell....yes, then it goes to hell. No one needs to sit and remind others that it can go to hell. Everyone knows that, but it can also go to heaven and that is probably why we are here.....·6 min sittenNo stop stop stop, when something forms a blow off top, it will undeniably make a violent correction as well, people said exactly the same about pixelfox, GME, AMC and all other times it has happened, and 10/10 times there is a huge correction when people take profit.
- ·56 min sittenthis is high risk, high reward. if the company is not acquired by the giants e.g. Pfizer, Roche, Novartis then they can collapse and it is common to see biotech companies collapse when they run out of money·27 min sittenI myself lost some money in BergenBio when it was hyped up to the sky. But I feel much safer here, these two are not comparable. But just a reminder that one must do their own research and not just read in the forums
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 2 500 | - | - | ||
| 1 000 | - | - | ||
| 4 700 | - | - | ||
| 2 470 | - | - | ||
| 2 500 | - | - |
Välittäjätilasto
Dataa ei löytynyt